J&J Janssen COVID-19 Vaccinations Paused in the USA

The US Food and Drug Administration (FDA) and Centers for Disease Control and Prevention jointly announced on Twitter their recommendation 'pausing the use of the Johnson & Johnson - Janssen COVID-19 vaccine out of an abundance of caution .' 13, 2021.

These agencies stated they are reviewing data involving rare and severe blood clot cases in individuals after receiving the Janssen COVID-19 vaccine.

'Right now, these adverse events appear to be extremely rare,' stated the FDA's Tweet. 'Treatment of this specific type of blood clot is different from the treatment that might typically be administered.'

The European Medicines Agency previously announced it had started a review of a safety signal to assess reports of thromboembolic events in people who received COVID-19 Vaccine Janssen on April 9, 2021.